Enhancing Cancer Registries for Early Case Capture (ECC) of Pediatric and Young Adult Cancer (PYAC) Cases

Post Date

May 2nd 2014

Application Due Date

July 2nd 2014

A. Dates: 1. Letter of Intent (LOI) Deadline: LOI is requested, but not required. If submitted, due date is May 30, 2014 2. Application Deadline: July 2, 2014, 11:59 p.m. U.S. Eastern Standard Time, on www.grants.gov Conference Call: May 22

Funding Opportunity Number

CDC-RFA-DP14-1402

CFDA Number(s)

93.283

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

9

Eligibility Categories

Other

A. Eligibility Information Eligible applicants for this FOA are included in this section. 1. Eligible Applicants: Government Organizations: ╔ Currently funded DP12-1205 Component 4 Grantees (National Program of Cancer Registries) or their Bona Fide Agent. 2. Special Eligibility Requirements: Applicant must implement statewide, population-based, PYAC data collection for ECC.

Funding

• Estimated Total Funding:

  $1500000

• Award Range:

  $0 - $0

Grant Description

The purpose of this FOA is to support ongoing implementation of the Caroline Pryce Walker Conquer Childhood Cancer Act by enhancing central cancer registry infrastructure to facilitate early case capture (ECC) of pediatric cancer cases within weeks of diagnosis. This project was previously funded through DP11-1107, a 3-year FOA. This new FOA will allow for ongoing enhancement and possible expansion to additional grantees, who will establish methods for rapid reporting, primarily through the use of electronic reporting from all sources of PYAC cases, including large out-of-state childrenуs hospitals. Grantees will implement procedures to monitor and ensure data quality, completeness and timeliness, submit PYAC data to CDC bi-annually, and increase availability of this data for surveillance, epidemiology, and research at the local, state, and national level. By the end of this 5-year project period, grantees will achieve the primary outcomes including increased facility knowledge of PYAC ECC and ability to report an increased percent of cases within 30 days of diagnosis, increased researcher access to more timely PYAC cancer data, and more evidence-based decisions by PYAC healthcare providers, programs, and key stakeholders. In the long-term, these project period outcomes will lead to increased knowledge of PYAC etiology, treatment efficacy, and late effects of specific cancers, increased public health interventions and clinical trial enrollment, and ultimately decreased PYAC incidence and mortality and increased survival.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC Procurement and Grants Office
  (PGO) Technical Information Management Section (TIMS)
  Phone: 770-488-2700
  E-mail: pgotim@cdc.gov
  

• Agency Mailing Address:

  Technical Information Management Section (TIMS)

• Agency Email Address:

  pgotim@cdc.gov

• More Information:

  Please click on Full Announcement at the top of this page